Selected research
Market Outlook & Growth Opportunities
Global Exosome Isolation Kits Market Outlook and Growth Opportunities 2026
Market perspective
The global Exosome Isolation Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Exosome Isolation Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Exosome Isolation Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Isolation Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Exosome Isolation Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Exosome Isolation Kits market include QIAGEN, Thermo Fisher Scientific, Vazyme, TransGen Biotech, System Biosciences, Norgen Biotek, Miltenyi Biotec, Lonza and Cusabio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Exosome Isolation Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Exosome Isolation Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Exosome Isolation Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exosome Isolation Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
Exosome Isolation Kits Segment by Company
QIAGEN
Thermo Fisher Scientific
Vazyme
TransGen Biotech
System Biosciences
Norgen Biotek
Miltenyi Biotec
Lonza
Cusabio
BioVision
AMS Biotechnology
Exosome Isolation Kits Segment by Type
Plasma and Serum Exosome Isolation Kits
Cell Culture Medium Exosome Isolation Kits
Urine Exosome Isolation Kits
Others
Exosome Isolation Kits Segment by Application
Healthcare Providers
Pharmaceutical and Biotechnology Companies
Others
Exosome Isolation Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Exosome Isolation Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Exosome Isolation Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Exosome Isolation Kits significant trends, drivers, influence factors in global and regions.
6. To analyze Exosome Isolation Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Exosome Isolation Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Isolation Kits industry.
Chapter 3: Detailed analysis of Exosome Isolation Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Exosome Isolation Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Exosome Isolation Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasma and Serum Exosome Isolation Kits
- Cell Culture Medium Exosome Isolation Kits
- Urine Exosome Isolation Kits
- Others
Applications
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Others
Companies covered
- QIAGEN
- Thermo Fisher Scientific
- Vazyme
- TransGen Biotech
- System Biosciences
- Norgen Biotek
- Miltenyi Biotec
- Lonza
- Cusabio
- BioVision
- AMS Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Exosome Isolation Kits Sales Value (2021-2032)
- 1.2.2 Global Exosome Isolation Kits Sales Volume (2021-2032)
- 1.2.3 Global Exosome Isolation Kits Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Exosome Isolation Kits Market Dynamics
- 2.1 Exosome Isolation Kits Industry Trends
- 2.2 Exosome Isolation Kits Industry Drivers
- 2.3 Exosome Isolation Kits Industry Opportunities and Challenges
- 2.4 Exosome Isolation Kits Industry Restraints
3 Exosome Isolation Kits Market by Company
- 3.1 Global Exosome Isolation Kits Company Revenue Ranking in 2025
- 3.2 Global Exosome Isolation Kits Revenue by Company (2021-2026)
- 3.3 Global Exosome Isolation Kits Sales Volume by Company (2021-2026)
- 3.4 Global Exosome Isolation Kits Average Price by Company (2021-2026)
- 3.5 Global Exosome Isolation Kits Company Ranking (2024-2026)
- 3.6 Global Exosome Isolation Kits Company Manufacturing Base and Headquarters
- 3.7 Global Exosome Isolation Kits Company Product Type and Application
- 3.8 Global Exosome Isolation Kits Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Exosome Isolation Kits Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Exosome Isolation Kits Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Exosome Isolation Kits Market by Type
- 4.1 Exosome Isolation Kits Type Introduction
- 4.1.1 Plasma and Serum Exosome Isolation Kits
- 4.1.2 Cell Culture Medium Exosome Isolation Kits
- 4.1.3 Urine Exosome Isolation Kits
- 4.1.4 Others
- 4.2 Global Exosome Isolation Kits Sales Volume by Type
- 4.2.1 Global Exosome Isolation Kits Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Exosome Isolation Kits Sales Volume by Type (2021-2032)
- 4.2.3 Global Exosome Isolation Kits Sales Volume Share by Type (2021-2032)
- 4.3 Global Exosome Isolation Kits Sales Value by Type
- 4.3.1 Global Exosome Isolation Kits Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Exosome Isolation Kits Sales Value by Type (2021-2032)
- 4.3.3 Global Exosome Isolation Kits Sales Value Share by Type (2021-2032)
5 Exosome Isolation Kits Market by Application
- 5.1 Exosome Isolation Kits Application Introduction
- 5.1.1 Healthcare Providers
- 5.1.2 Pharmaceutical and Biotechnology Companies
- 5.1.3 Others
- 5.2 Global Exosome Isolation Kits Sales Volume by Application
- 5.2.1 Global Exosome Isolation Kits Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Exosome Isolation Kits Sales Volume by Application (2021-2032)
- 5.2.3 Global Exosome Isolation Kits Sales Volume Share by Application (2021-2032)
- 5.3 Global Exosome Isolation Kits Sales Value by Application
- 5.3.1 Global Exosome Isolation Kits Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Exosome Isolation Kits Sales Value by Application (2021-2032)
- 5.3.3 Global Exosome Isolation Kits Sales Value Share by Application (2021-2032)
6 Exosome Isolation Kits Regional Sales and Value Analysis
- 6.1 Global Exosome Isolation Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Exosome Isolation Kits Sales by Region (2021-2032)
- 6.2.1 Global Exosome Isolation Kits Sales by Region: 2021-2026
- 6.2.2 Global Exosome Isolation Kits Sales by Region (2027-2032)
- 6.3 Global Exosome Isolation Kits Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Exosome Isolation Kits Sales Value by Region (2021-2032)
- 6.4.1 Global Exosome Isolation Kits Sales Value by Region: 2021-2026
- 6.4.2 Global Exosome Isolation Kits Sales Value by Region (2027-2032)
- 6.5 Global Exosome Isolation Kits Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Exosome Isolation Kits Sales Value (2021-2032)
- 6.6.2 North America Exosome Isolation Kits Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Exosome Isolation Kits Sales Value (2021-2032)
- 6.7.2 Europe Exosome Isolation Kits Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Exosome Isolation Kits Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Exosome Isolation Kits Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Exosome Isolation Kits Sales Value (2021-2032)
- 6.9.2 South America Exosome Isolation Kits Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Exosome Isolation Kits Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Exosome Isolation Kits Sales Value Share by Country, 2025 VS 2032
7 Exosome Isolation Kits Country-level Sales and Value Analysis
- 7.1 Global Exosome Isolation Kits Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Exosome Isolation Kits Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Exosome Isolation Kits Sales by Country (2021-2032)
- 7.3.1 Global Exosome Isolation Kits Sales by Country (2021-2026)
- 7.3.2 Global Exosome Isolation Kits Sales by Country (2027-2032)
- 7.4 Global Exosome Isolation Kits Sales Value by Country (2021-2032)
- 7.4.1 Global Exosome Isolation Kits Sales Value by Country (2021-2026)
- 7.4.2 Global Exosome Isolation Kits Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.9.2 France Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.16.2 China Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.19.2 India Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Exosome Isolation Kits Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Exosome Isolation Kits Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Exosome Isolation Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 QIAGEN
- 8.1.1 QIAGEN Company Information
- 8.1.2 QIAGEN Business Overview
- 8.1.3 QIAGEN Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.1.4 QIAGEN Exosome Isolation Kits Product Portfolio
- 8.1.5 QIAGEN Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Exosome Isolation Kits Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Vazyme
- 8.3.1 Vazyme Company Information
- 8.3.2 Vazyme Business Overview
- 8.3.3 Vazyme Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Vazyme Exosome Isolation Kits Product Portfolio
- 8.3.5 Vazyme Recent Developments
- 8.4 TransGen Biotech
- 8.4.1 TransGen Biotech Company Information
- 8.4.2 TransGen Biotech Business Overview
- 8.4.3 TransGen Biotech Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.4.4 TransGen Biotech Exosome Isolation Kits Product Portfolio
- 8.4.5 TransGen Biotech Recent Developments
- 8.5 System Biosciences
- 8.5.1 System Biosciences Company Information
- 8.5.2 System Biosciences Business Overview
- 8.5.3 System Biosciences Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.5.4 System Biosciences Exosome Isolation Kits Product Portfolio
- 8.5.5 System Biosciences Recent Developments
- 8.6 Norgen Biotek
- 8.6.1 Norgen Biotek Company Information
- 8.6.2 Norgen Biotek Business Overview
- 8.6.3 Norgen Biotek Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Norgen Biotek Exosome Isolation Kits Product Portfolio
- 8.6.5 Norgen Biotek Recent Developments
- 8.7 Miltenyi Biotec
- 8.7.1 Miltenyi Biotec Company Information
- 8.7.2 Miltenyi Biotec Business Overview
- 8.7.3 Miltenyi Biotec Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Miltenyi Biotec Exosome Isolation Kits Product Portfolio
- 8.7.5 Miltenyi Biotec Recent Developments
- 8.8 Lonza
- 8.8.1 Lonza Company Information
- 8.8.2 Lonza Business Overview
- 8.8.3 Lonza Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Lonza Exosome Isolation Kits Product Portfolio
- 8.8.5 Lonza Recent Developments
- 8.9 Cusabio
- 8.9.1 Cusabio Company Information
- 8.9.2 Cusabio Business Overview
- 8.9.3 Cusabio Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Cusabio Exosome Isolation Kits Product Portfolio
- 8.9.5 Cusabio Recent Developments
- 8.10 BioVision
- 8.10.1 BioVision Company Information
- 8.10.2 BioVision Business Overview
- 8.10.3 BioVision Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.10.4 BioVision Exosome Isolation Kits Product Portfolio
- 8.10.5 BioVision Recent Developments
- 8.11 AMS Biotechnology
- 8.11.1 AMS Biotechnology Company Information
- 8.11.2 AMS Biotechnology Business Overview
- 8.11.3 AMS Biotechnology Exosome Isolation Kits Sales, Value and Gross Margin (2021-2026)
- 8.11.4 AMS Biotechnology Exosome Isolation Kits Product Portfolio
- 8.11.5 AMS Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Exosome Isolation Kits Value Chain Analysis
- 9.1.1 Exosome Isolation Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Exosome Isolation Kits Sales Mode & Process
- 9.2 Exosome Isolation Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Exosome Isolation Kits Distributors
- 9.2.3 Exosome Isolation Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst